New italian network aims to catch rare disease early

NCT ID NCT06383143

Recruiting now Diagnosis Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia Source: ClinicalTrials.gov ↗

First seen Apr 21, 2026 · Last updated Apr 30, 2026 · Updated 1 time

Summary

This study connects Italian hospitals to a specialized center to find AL amyloidosis earlier. Researchers will screen 760 people with related blood conditions using new biomarker tests. The goal is to speed up diagnosis and treatment, and to learn more about the disease.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Azienda Ospedaliera Policlinico Consorziale
RECRUITING

Bari, Italy

Contact

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact
Azienda Ospedaliero Universitaria Policlinico G.Rodolico - San Marco
RECRUITING

Catania, Italy

Contact

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact
EMATOLOGIA - Città della Scienza e Salute - Torino
RECRUITING

Torino, Italy

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact

Contact
Fondazione Irccs Policlinico San Matteo
RECRUITING

Pavia, Italy

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact

Contact

Contact

Conditions

Explore the condition pages connected to this study.

AL AMYLOIDOSIS AL AMYLOIDOSIS MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE SMOLDERING MULTIPLE MYELOMA